Overview
Juvenile neuronal ceroid lipofuscinosis (JNCL, Batten disease) is an autosomal recessive lysosomal storage disorder characterized by the accumulation of ceroid-lipofuscin, leading to progressive neurological deterioration including vision loss, seizures, and motor dysfunction, typically resulting in premature death around age 30 1.Diagnosis
Clinical Presentation: Loss of vision in childhood, followed by seizures, motor dysfunction, and cognitive decline 1.
Genetic Testing: Essential for confirmation; common mutation is a 1.02 kb deletion in CLN3 gene, but novel mutations like c.597C>A (p.Y199X) can also cause the disease 1.
Electron Microscopy: Lymphocytes showing fingerprint profiles indicative of JNCL 1.
Family History: Important, especially in consanguineous families where disease clustering may occur 1.Management
No Cure Available: Current management focuses on supportive care and symptom control 1.
Seizure Control: Antiepileptic drugs tailored to seizure types (e.g., valproate, levetiracetam) 1.
Motor and Cognitive Support: Physical and occupational therapy to maintain function 1.
Vision Aids: Low-vision aids and regular ophthalmological follow-up 1.
Nutritional Support: Ensuring adequate nutrition and addressing feeding difficulties 1.
Psychosocial Support: Multidisciplinary approach including psychological support for patients and families 1.Special Populations
Pediatrics: Early diagnosis and intervention crucial for managing symptoms and improving quality of life 1.
Comorbidities: Management of comorbidities like epilepsy requires individualized treatment plans 1.Key Recommendations
Genetic Testing for Diagnosis: Confirm diagnosis through genetic testing, including screening for novel CLN3 mutations (Evidence: Moderate 1).
Multidisciplinary Care Approach: Implement a comprehensive care plan involving neurology, ophthalmology, physical therapy, and psychosocial support (Evidence: Expert opinion 1).
Seizure Management: Tailor antiepileptic drug therapy based on seizure types and clinical response (Evidence: Moderate 1).References
1 Sarpong A, Schottmann G, Rüther K, Stoltenburg G, Kohlschütter A, Hübner C et al.. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Clinical genetics 2009. link